Literature DB >> 30740584

MicroRNA Profile Differences in Neonates at Risk for Cerebral Palsy.

S D Chapman1, L Farina2, K Kronforst3, Mlv Dizon3.   

Abstract

BACKGROUND: MicroRNAs; miRs are used as biomarkers in the diagnosis of several diseases. Cerebral palsy; CP, resulting from perinatal brain injury, cannot be diagnosed until 18-24 months old. Biomarkers to predict CP and assess response to investigational therapies are needed. We hypothesized that miRs expressed in neonates with the CP risk factors of abnormal tone and/or intraventricular hemorrhage; IVH differ from those without risk factors.
METHODS: This was a cohort study of neonates at risk for CP. Subjects <32 weeks gestation and <1500 grams were recruited from neonatal intensive care units at a large urban delivery hospital and an adjacent children's hospital. Thirty-one plasma samples were evaluated. An unbiased examination was performed by locked nucleic acid quantitative real time - polymerase chain reaction; qRT-PCR. Results were evaluated in the context of IVH and abnormal tone.
RESULTS: Plasma miR profiles in neonates at risk for CP differ when comparing those with and without IVH, and with and without abnormal tone. Restricted profiles were found in each condition with greater differences in the tone comparison than the IVH comparison.
CONCLUSION: Plasma miR profiles show potential in predicting CP. This study also suggests biologically plausible candidates for future studies.

Entities:  

Keywords:  Biomarkers; Cerebral palsy; MicroRNAs

Year:  2018        PMID: 30740584      PMCID: PMC6364989     

Source DB:  PubMed          Journal:  Phys Med Rehabil Int        ISSN: 2471-0377


  23 in total

1.  SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores.

Authors:  D K Richardson; J D Corcoran; G J Escobar; S K Lee
Journal:  J Pediatr       Date:  2001-01       Impact factor: 4.406

Review 2.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

3.  A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA).

Authors:  Mirco Castoldi; Sabine Schmidt; Vladimir Benes; Mikkel Noerholm; Andreas E Kulozik; Matthias W Hentze; Martina U Muckenthaler
Journal:  RNA       Date:  2006-03-15       Impact factor: 4.942

4.  A report: the definition and classification of cerebral palsy April 2006.

Authors:  Peter Rosenbaum; Nigel Paneth; Alan Leviton; Murray Goldstein; Martin Bax; Diane Damiano; Bernard Dan; Bo Jacobsson
Journal:  Dev Med Child Neurol Suppl       Date:  2007-02

5.  Expression profile of MicroRNAs in young stroke patients.

Authors:  Kay Sin Tan; Arunmozhiarasi Armugam; Sugunavathi Sepramaniam; Kai Ying Lim; Karolina Dwi Setyowati; Chee Woon Wang; Kandiah Jeyaseelan
Journal:  PLoS One       Date:  2009-11-02       Impact factor: 3.240

Review 6.  Pathogenesis of cerebral white matter injury of prematurity.

Authors:  O Khwaja; J J Volpe
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2008-03       Impact factor: 5.747

Review 7.  Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review.

Authors:  E Himpens; C Van den Broeck; A Oostra; P Calders; P Vanhaesebrouck
Journal:  Dev Med Child Neurol       Date:  2008-03-18       Impact factor: 5.449

8.  Neonatal brain magnetic resonance imaging before discharge is better than serial cranial ultrasound in predicting cerebral palsy in very low birth weight preterm infants.

Authors:  Majid Mirmiran; Patrick D Barnes; Kathy Keller; Janet C Constantinou; Barry E Fleisher; Susan R Hintz; Ronald L Ariagno
Journal:  Pediatrics       Date:  2004-10       Impact factor: 7.124

9.  Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  S Ashwal; B S Russman; P A Blasco; G Miller; A Sandler; M Shevell; R Stevenson
Journal:  Neurology       Date:  2004-03-23       Impact factor: 9.910

10.  MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion.

Authors:  Kandiah Jeyaseelan; Kai Ying Lim; Arunmozhiarasi Armugam
Journal:  Stroke       Date:  2008-02-07       Impact factor: 7.914

View more
  3 in total

1.  Differential Gene Expression in Cord Blood of Infants Diagnosed with Cerebral Palsy: A Pilot Analysis of the Beneficial Effects of Antenatal Magnesium Cohort.

Authors:  Maria L V Dizon; Raye-Ann O deRegnier; Steven J Weiner; Michael W Varner; Dwight J Rouse; Maged M Costantine; Ronald J Wapner; John M Thorp; Sean C Blackwell; Nina K Ayala; Antonio F Saad; Steve N Caritis
Journal:  Dev Neurosci       Date:  2022-06-15       Impact factor: 3.421

Review 2.  An Emerging Role for Epigenetics in Cerebral Palsy.

Authors:  Brigette Romero; Karyn G Robinson; Mona Batish; Robert E Akins
Journal:  J Pers Med       Date:  2021-11-12

3.  Intrauterine growth restriction followed by oxygen support uniquely interferes with genetic regulators of myelination.

Authors:  Jill Chang; Robert H Lurie; Abhineet Sharma; Mirrah Bashir; Camille M Fung; Robert W Dettman; Maria L V Dizon
Journal:  eNeuro       Date:  2021-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.